Skip to main content

Nutrition Support in Hemodialysis and Peritoneal Dialysis

  • Chapter
  • First Online:
Nutrition in Kidney Disease

Part of the book series: Nutrition and Health ((NH))

Abstract

Protein-energy wasting (PEW) is common among patients undergoing maintenance dialysis, and many signs of PEW can be improved with nutrition support therapy. Early and regular nutrition counseling by registered dietitian (or international equivalent) is essential for the prevention and treatment of PEW in maintenance dialysis patients. When nutrition counseling alone is unable to bridge the gap between protein-energy intake and the target requirements, oral nutritional supplements (ONS) should be prescribed to improve nutritional status. When maintenance dialysis patients with PEW are unable to meet protein and energy requirements with nutrition counseling and ONS, enteral tube feeding should be considered. Intradialytic parenteral nutrition (IDPN) should only be used as supplemental nutrition in hemodialysis patients with PEW, and adequate spontaneous protein and energy intakes are required to compensate for the difference between those provided by IDPN and the target requirements. Intradialytic amino acid therapy remains a viable option for protein-energy wasted peritoneal dialysis patients with insufficient dietary intake, as well as those with tolerance, compliance, and suitability issues of oral intake and other forms of enteral supplementation.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 109.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 139.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Carrero JJ, Stenvinkel P, Cuppari L, Ikizler TA, Kalantar-Zadeh K, Kaysen G, et al. Etiology of the protein-energy wasting syndrome in chronic kidney disease: a consensus statement from the International Society of Renal Nutrition and Metabolism (ISRNM). J Ren Nutr. 2013;23(2):77–90.

    Article  PubMed  Google Scholar 

  2. Kovesdy CP, Kopple JD, Kalantar-Zadeh K. Management of protein-energy wasting in non-dialysis-dependent chronic kidney disease: reconciling low protein intake with nutritional therapy. Am J Clin Nutr. 2013;97(6):1163–77.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Lodebo BT, Shah A, Kopple JD. Is it important to prevent and treat protein-energy wasting in chronic kidney disease and chronic dialysis patients? J Ren Nutr. 2018;28(6):369–79.

    Article  CAS  PubMed  Google Scholar 

  4. Fouque D, Kalantar-Zadeh K, Kopple J, Cano N, Chauveau P, Cuppari L, et al. A proposed nomenclature and diagnostic criteria for protein-energy wasting in acute and chronic kidney disease. Kidney Int. 2008;73(4):391–8.

    Article  CAS  PubMed  Google Scholar 

  5. Carrero JJ, Thomas F, Nagy K, Arogundade F, Avesani CM, Chan M, et al. Global prevalence of protein-energy wasting in kidney disease: ameta-analysis of contemporary observational studies from the International Society of Renal Nutrition and Metabolism. J Ren Nutr. 2018;28(6):380–92.

    Article  PubMed  Google Scholar 

  6. Chertow GM, Johansen KL, Lew N, Lazarus JM, Lowrie EG. Vintage, nutritional status, and survival in hemodialysis patients. Kidney Int. 2000;57(3):1176–81.

    Article  CAS  PubMed  Google Scholar 

  7. den Hoedt CH, Bots ML, Grooteman MP, van der Weerd NC, Penne EL, Mazairac AH, et al. Clinical predictors of decline in nutritional parameters over time in ESRD. Clin J Am Soc Nephrol. 2014;9(2):318–25.

    Article  CAS  Google Scholar 

  8. Avram MM, Mittman N, Fein PA, Agahiu S, Hartman W, Chattopadhyay N, et al. Dialysis vintage, body composition, and survival in peritoneal dialysis patients. Adv Perit Dial. 2012;28:144–7.

    PubMed  Google Scholar 

  9. Sabatino A, Regolisti G, Karupaiah T, Sahathevan S, Sadu Singh BK, Khor BH, et al. Protein-energy wasting and nutritional supplementation in patients with end-stage renal disease on hemodialysis. Clin Nutr. 2017;36(3):663–71.

    Article  CAS  PubMed  Google Scholar 

  10. Ikizler TA, Cano NJ, Franch H, Fouque D, Himmelfarb J, Kalantar-Zadeh K, et al. Prevention and treatment of protein energy wasting in chronic kidney disease patients: a consensus statement by the International Society of Renal Nutrition and Metabolism. Kidney Int. 2013;84(6):1096–107.

    Article  CAS  PubMed  Google Scholar 

  11. Cano NJ. Chapter 39: Oral and enteral supplements in kidney disease and kidney failure. In: Nutritional management of renal disease. Amsterdam: Elsevier; 2013. p. 659–72.

    Google Scholar 

  12. Lindholm B, Wang T, Heimburger O, Bergstrom J. Influence of different treatments and schedules on the factors conditioning the nutritional status in dialysis patients. Nephrol Dial Transplant. 1998;13(Suppl 6):66–73.

    Article  PubMed  Google Scholar 

  13. Laville M, Fouque D. Nutritional aspects in hemodialysis. Kidney Int. 2000;58:S133–S9.

    Article  Google Scholar 

  14. Velloso MS, Otoni A, de Paula SA, de Castro WV, Pinto SW, Marinho MA, et al. Peritoneal dialysis and inflammation. Clinica chimica acta. Int JClin Chem. 2014;430:109–14.

    Google Scholar 

  15. Cano N, Fiaccadori E, Tesinsky P, Toigo G, Druml W, Kuhlmann M, et al. ESPEN guidelines on enteral nutrition: adult renal failure. Clin Nutr. 2006;25(2):295–310.

    Article  CAS  PubMed  Google Scholar 

  16. Ikizler TA, Burrowes J, Byham-Gray L, Campbell K, Carrero JJ, Chan W, et al. KDOQI Nutrition in CKD Guideline Work Group. KDOQI clinical practice guideline for nutrition in CKD: 2020 update. Am J Kidney Dis. 2020; in press.

    Google Scholar 

  17. Fouque D, Vennegoor M, ter Wee P, Wanner C, Basci A, Canaud B, et al. EBPG guideline on nutrition. Nephrol Dial Transplant. 2007;22(Suppl 2):ii45–87.

    PubMed  Google Scholar 

  18. Dombros N, Dratwa M, Feriani M, Gokal R, Heimburger O, Krediet R, et al. European best practice guidelines for peritoneal dialysis. 8 Nutrition in peritoneal dialysis. Nephrol Dial Transplant. 2005;20(Suppl 9):ix28–33.

    PubMed  Google Scholar 

  19. Blumenkrantz MJ, Gahl GM, Kopple JD, Kamdar AV, Jones MR, Kessel M, et al. Protein losses during peritoneal dialysis. Kidney Int. 1981;19(4):593–602.

    Article  CAS  PubMed  Google Scholar 

  20. Shah A, Bross R, Shapiro BB, Morrison G, Kopple JD. Dietary energy requirements in relatively healthy maintenance hemodialysis patients estimated from long-term metabolic studies. Am J Clin Nutr. 2016;103(3):757–65.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  21. Leon JB, Majerle AD, Soinski JA, Kushner I, Ohri-Vachaspati P, Sehgal AR. Can a nutrition intervention improve albumin levels among hemodialysis patients? A pilot study. J Ren Nutr. 2001;11(1):9–15.

    Article  CAS  PubMed  Google Scholar 

  22. Prasad N, Gupta A, Sinha A, Sharma RK, Kumar A, Kumar R. Changes in nutritional status on follow-up of an incident cohort of continuous ambulatory peritoneal dialysis patients. J Ren Nutr. 2008;18(2):195–201.

    Article  PubMed  Google Scholar 

  23. Shinaberger CS, Greenland S, Kopple JD, Van Wyck D, Mehrotra R, Kovesdy CP, et al. Is controlling phosphorus by decreasing dietary protein intake beneficial or harmful in persons with chronic kidney disease? Am J Clin Nutr. 2008;88(6):1511–8.

    Article  CAS  PubMed  Google Scholar 

  24. Cupisti A, Kalantar-Zadeh K. Management of natural and added dietary phosphorus burden in kidney disease. Semin Nephrol. 2013;33(2):180–90.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  25. Moe SM, Zidehsarai MP, Chambers MA, Jackman LA, Radcliffe JS, Trevino LL, et al. Vegetarian compared with meat dietary protein source and phosphorus homeostasis in chronic kidney disease. Clin J Am Soc Nephrol. 2011;6(2):257–64.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  26. Chen X, Wei G, Jalili T, Metos J, Giri A, Cho ME, et al. The associations of plant protein intake with all-cause mortality in CKD. Am J Kidney Dis. 2016;67(3):423–30.

    Article  CAS  PubMed  Google Scholar 

  27. D’Alessandro C, Piccoli GB, Cupisti A. The “phosphorus pyramid”: a visual tool for dietary phosphate management in dialysis and CKD patients. BMC Nephrol. 2015;16:9.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  28. Cano NJ, Aparicio M, Brunori G, Carrero JJ, Cianciaruso B, Fiaccadori E, et al. ESPEN guidelines on parenteral nutrition: adult renal failure. Clin Nutr. 2009;28(4):401–14.

    Article  CAS  PubMed  Google Scholar 

  29. Veeneman JM, Kingma HA, Boer TS, Stellaard F, De Jong PE, Reijngoud DJ, et al. Protein intake during hemodialysis maintains a positive whole body protein balance in chronic hemodialysis patients. Am J Physiol Endocrinol Metab. 2003;284(5):E954–65.

    Article  CAS  PubMed  Google Scholar 

  30. Pupim LB, Majchrzak KM, Flakoll PJ, Ikizler TA. Intradialytic oral nutrition improves protein homeostasis in chronic hemodialysis patients with deranged nutritional status. J Am Soc Nephrol. 2006;17(11):3149–57.

    Article  CAS  PubMed  Google Scholar 

  31. Calegari A, Barros EG, Veronese FV, Thome FS. Malnourished patients on hemodialysis improve after receiving a nutritional intervention. J Bras Nefrol. 2011;33(4):394–401.

    Article  PubMed  Google Scholar 

  32. Wilson B, Fernandez-Madrid A, Hayes A, Hermann K, Smith J, Wassell A. Comparison of the effects of two early intervention strategies on the health outcomes of malnourished hemodialysis patients. J Ren Nutr. 2001;11(3):166–71.

    Article  CAS  PubMed  Google Scholar 

  33. Fouque D, McKenzie J, de Mutsert R, Azar R, Teta D, Plauth M, et al. Use of a renal-specific oral supplement by haemodialysis patients with low protein intake does not increase the need for phosphate binders and may prevent a decline in nutritional status and quality of life. Nephrol Dial Transplant. 2008;23(9):2902–10.

    Article  CAS  PubMed  Google Scholar 

  34. Hung SC, Tarng DC. Adiposity and insulin resistance in nondiabetic hemodialysis patients: effects of high energy supplementation. Am J Clin Nutr. 2009;90(1):64–9.

    Article  CAS  PubMed  Google Scholar 

  35. Cano NJ, Fouque D, Roth H, Aparicio M, Azar R, Canaud B, et al. Intradialytic parenteral nutrition does not improve survival in malnourished hemodialysis patients: a 2-year multicenter, prospective, randomized study. J Am Soc Nephrol. 2007;18(9):2583–91.

    Article  CAS  PubMed  Google Scholar 

  36. Hiroshige K, Sonta T, Suda T, Kanegae K, Ohtani A. Oral supplementation of branched-chain amino acid improves nutritional status in elderly patients on chronic haemodialysis. Nephrol Dial Transplant. 2001;16(9):1856–62.

    Article  CAS  PubMed  Google Scholar 

  37. Bolasco P, Caria S, Cupisti A, Secci R, Saverio DF. A novel amino acids oral supplementation in hemodialysis patients: a pilot study. Ren Fail. 2011;33(1):1–5.

    Article  CAS  PubMed  Google Scholar 

  38. Tomayko EJ, Kistler BM, Fitschen PJ, Wilund KR. Intradialytic protein supplementation reduces inflammation and improves physical function in maintenance hemodialysis patients. J Ren Nutr. 2015;25(3):276–83.

    Article  CAS  PubMed  Google Scholar 

  39. Allman MA, Stewart PM, Tiller DJ, Horvath JS, Duggin GG, Truswell AS. Energy supplementation and the nutritional status of hemodialysis patients. Am J Clin Nutr. 1990;51(4):558–62.

    Article  CAS  PubMed  Google Scholar 

  40. Moretti HD, Johnson AM, Keeling-Hathaway TJ. Effects of protein supplementation in chronic hemodialysis and peritoneal dialysis patients. J Ren Nutr. 2009;19(4):298–303.

    Article  CAS  PubMed  Google Scholar 

  41. Cheu C, Pearson J, Dahlerus C, Lantz B, Chowdhury T, Sauer PF, et al. Association between oral nutritional supplementation and clinical outcomes among patients with ESRD. Clin J Am Soc Nephrol. 2013;8(1):100–7.

    Article  PubMed  Google Scholar 

  42. Scott MK, Shah NA, Vilay AM, Thomas J 3rd, Kraus MA, Mueller BA. Effects of peridialytic oral supplements on nutritional status and quality of life in chronic hemodialysis patients. J Ren Nutr. 2009;19(2):145–52.

    Article  PubMed  Google Scholar 

  43. Sezer S, Bal Z, Tutal E, Uyar ME, Acar NO. Long-term oral nutrition supplementation improves outcomes in malnourished patients with chronic kidney disease on hemodialysis. JPEN J Parenter Enteral Nutr. 2014;38(8):960–5.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  44. Teixido-Planas J, Ortiz A, Coronel F, Montenegro J, Lopez-Menchero R, Ortiz R, et al. Oral protein-energy supplements in peritoneal dialysis: a multicenter study. Perit Dial Int. 2005;25(2):163–72.

    Article  CAS  PubMed  Google Scholar 

  45. Gonzalez-Espinoza L, Gutierrez-Chavez J, del Campo FM, Martinez-Ramirez HR, Cortes-Sanabria L, Rojas-Campos E, et al. Randomized, open label, controlled clinical trial of oral administration of an egg albumin-based protein supplement to patients on continuous ambulatory peritoneal dialysis. Perit Dial Int. 2005;25(2):173–80.

    Article  CAS  PubMed  Google Scholar 

  46. Lacson E Jr, Wang W, Zebrowski B, Wingard R, Hakim RM. Outcomes associated with intradialytic oral nutritional supplements in patients undergoing maintenance hemodialysis: a quality improvement report. Am J Kidney Dis. 2012;60(4):591–600.

    Article  CAS  PubMed  Google Scholar 

  47. Ricanati ES, Tserng KY, Kalhan SC. Glucose metabolism in chronic renal failure: adaptive responses to continuous glucose infusion. Kidney Int Suppl. 1983;16:S121–7.

    CAS  PubMed  Google Scholar 

  48. Schneeweiss B, Graninger W, Stockenhuber F, Druml W, Ferenci P, Eichinger S, et al. Energy metabolism in acute and chronic renal failure. Am J Clin Nutr. 1990;52(4):596–601.

    Article  CAS  PubMed  Google Scholar 

  49. Kalantar-Zadeh K, Ikizler TA. Let them eat during dialysis: an overlooked opportunity to improve outcomes in maintenance hemodialysis patients. J Ren Nutr. 2013;23(3):157–63.

    Article  PubMed  PubMed Central  Google Scholar 

  50. Kistler BM, Benner D, Burrowes JD, Campbell KL, Fouque D, Garibotto G, et al. Eating during hemodialysis treatment: aconsensus statement from the International Society of Renal Nutrition and Metabolism. J Ren Nutr. 2018;28(1):4–12.

    Article  PubMed  Google Scholar 

  51. Choi MS, Kistler B, Wiese GN, Stremke ER, Wright AJ, Moorthi RN, et al. Pilot study of the effects of high-protein meals during hemodialysis on intradialytic hypotension in patients undergoing maintenance hemodialysis. J Ren Nutr. 2019;29(2):102–11.

    Article  CAS  PubMed  Google Scholar 

  52. Cano NJM, Heng A-E. Nutritional problems in adult patients with stage 5 chronic kidney disease on dialysis (both haemodialysis and peritoneal dialysis). NDT Plus. 2009;3(2):109–17.

    Google Scholar 

  53. Patel MG, Raftery MJ. Successful percutaneous endoscopic gastrostomy feeding in continuous ambulatory peritoneal dialysis. J Ren Nutr. 1997;7(4):208–11.

    Article  Google Scholar 

  54. Fein PA, Madane SJ, Jorden A, Babu K, Mushnick R, Avram MM, et al. Outcome of percutaneous endoscopic gastrostomy feeding in patients on peritoneal dialysis. Adv Perit Dial. 2001;17:148–52.

    CAS  PubMed  Google Scholar 

  55. Paudel K, Fan SL. Successful use of continuous ambulatory peritoneal dialysis in 2 adults with a gastrostomy. Am J Kidney Dis. 2014;64(2):316–7.

    Article  PubMed  Google Scholar 

  56. Rubin J. Nutritional support during peritoneal dialysis-related peritonitis. Am J Kidney Dis. 1990;15(6):551–5.

    Article  CAS  PubMed  Google Scholar 

  57. de Freitas D, Jordaan A, Williams R, Alderdice J, Curwell J, Hurst H, et al. Nutritional management of patients undergoing surgery following diagnosis with encapsulating peritoneal sclerosis. Perit Dial Int. 2008;28(3):271–6.

    Article  PubMed  Google Scholar 

  58. Sayce HA, Rowe PA, McGonigle RJS. Percutaneous endoscopic gastrostomy feeding in haemodialysis out-patients. J Hum Nutr Diet. 2000;13(5):333–41.

    Article  Google Scholar 

  59. Holley JL, Kirk J. Enteral tube feeding in a cohort of chronic hemodialysis patients. J Ren Nutr. 2002;12(3):177–82.

    Article  PubMed  Google Scholar 

  60. Brown RO, Compher C. A.S.P.E.N. clinical guidelines: nutrition support in adult acute and chronic renal failure. JPEN J Parenter Enteral Nutr. 2010;34(4):366–77.

    Article  PubMed  Google Scholar 

  61. Sabatino A, Regolisti G, Antonucci E, Cabassi A, Morabito S, Fiaccadori E. Intradialytic parenteral nutrition in end-stage renal disease: practical aspects, indications and limits. J Nephrol. 2014;27(4):377–83.

    Article  CAS  PubMed  Google Scholar 

  62. Hoffer LJ. How much protein do parenteral amino acid mixtures provide? Am J Clin Nutr. 2011;94(6):1396–8.

    Article  CAS  PubMed  Google Scholar 

  63. Pupim LB, Flakoll PJ, Brouillette JR, Levenhagen DK, Hakim RM, Ikizler TA. Intradialytic parenteral nutrition improves protein and energy homeostasis in chronic hemodialysis patients. J Clin Invest. 2002;110(4):483–92.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  64. Pupim LB, Flakoll PJ, Ikizler TA. Nutritional supplementation acutely increases albumin fractional synthetic rate in chronic hemodialysis patients. J Am Soc Nephrol. 2004;15(7):1920–6.

    Article  CAS  PubMed  Google Scholar 

  65. Pupim LB, Flakoll PJ, Levenhagen DK, Ikizler TA. Exercise augments the acute anabolic effects of intradialytic parenteral nutrition in chronic hemodialysis patients. Am J Physiol Endocrinol Metab. 2004;286(4):E589–97.

    Article  CAS  PubMed  Google Scholar 

  66. Ikizler TA, Pupim LB, Brouillette JR, Levenhagen DK, Farmer K, Hakim RM, et al. Hemodialysis stimulates muscle and whole body protein loss and alters substrate oxidation. Am J Physiol Endocrinol Metab. 2002;282(1):E107–16.

    Article  CAS  PubMed  Google Scholar 

  67. Guarnieri G, Faccini L, Lipartiti T, Ranieri F, Spangaro F, Giuntini D, et al. Simple methods for nutritional assessment in hemodialyzed patients. Am J Clin Nutr. 1980;33(7):1598–607.

    Article  CAS  PubMed  Google Scholar 

  68. Cano N, Labastie-Coeyrehourq J, Lacombe P, Stroumza P, di Costanzo-Dufetel J, Durbec JP, et al. Perdialytic parenteral nutrition with lipids and amino acids in malnourished hemodialysis patients. Am J Clin Nutr. 1990;52(4):726–30.

    Article  CAS  PubMed  Google Scholar 

  69. Navarro JF, Mora C, Leon C, Martin-Del Rio R, Macia ML, Gallego E, et al. Amino acid losses during hemodialysis with polyacrylonitrile membranes: effect of intradialytic amino acid supplementation on plasma amino acid concentrations and nutritional variables in nondiabetic patients. Am J Clin Nutr. 2000;71(3):765–73.

    Article  CAS  PubMed  Google Scholar 

  70. Cano NJ, Saingra Y, Dupuy AM, Lorec-Penet AM, Portugal H, Lairon D, et al. Intradialytic parenteral nutrition: comparison of olive oil versus soybean oil-based lipid emulsions. Br J Nutr. 2006;95(1):152–9.

    Article  CAS  PubMed  Google Scholar 

  71. Marsen TA, Beer J, Mann H. Intradialytic parenteral nutrition in maintenance hemodialysis patients suffering from protein-energy wasting. Results of a multicenter, open, prospective, randomized trial. Clin Nutr. 2017;36(1):107–17.

    Article  PubMed  Google Scholar 

  72. Hiroshige K, Iwamoto M, Kabashima N, Mutoh Y, Yuu K, Ohtani A. Prolonged use of intradialysis parenteral nutrition in elderly malnourished chronic haemodialysis patients. Nephrol Dial Transplant. 1998;13(8):2081–7.

    Article  CAS  PubMed  Google Scholar 

  73. Toigo G, Situlin R, Tamaro G, Del Bianco A, Giuliani V, Dardi F, et al. Effect of intravenous supplementation of a new essential amino acid formulation in hemodialysis patients. Kidney Int Suppl. 1989;27:S278–81.

    CAS  PubMed  Google Scholar 

  74. Cranford W. Cost effectiveness of IDPN therapy measured by hospitalizations and length of stay. Nephrol News Issues. 1998;12(9):33–5, 7–9.

    CAS  PubMed  Google Scholar 

  75. Gosmanov AR, Umpierrez GE. Management of hyperglycemia during enteral and parenteral nutrition therapy. Curr Diab Rep. 2013;13(1):155–62.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  76. Moore E. Challenges of nutrition intervention for malnourished dialysis patients. J Infus Nurs. 2008;31(6):361–6.

    Article  PubMed  Google Scholar 

  77. Sarav M, Friedman AN. Use of intradialytic parenteral nutrition in patients undergoing hemodialysis. Nutr Clin Pract. 2018;33(6):767–71.

    Article  PubMed  Google Scholar 

  78. Kopple JD, Bernard D, Messana J, Swartz R, Bergstrom J, Lindholm B, et al. Treatment of malnourished CAPD patients with an amino acid based dialysate. Kidney Int. 1995;47(4):1148–57.

    Article  CAS  PubMed  Google Scholar 

  79. Li FK, Chan LY, Woo JC, Ho SK, Lo WK, Lai KN, et al. A 3-year, prospective, randomized, controlled study on amino acid dialysate in patients on CAPD. Am J Kidney Dis. 2003;42(1):173–83.

    Article  CAS  PubMed  Google Scholar 

  80. Jones M, Hagen T, Boyle CA, Vonesh E, Hamburger R, Charytan C, et al. Treatment of malnutrition with 1.1% amino acid peritoneal dialysis solution: results of a multicenter outpatient study. Am J Kidney Dis. 1998;32(5):761–9.

    Article  CAS  PubMed  Google Scholar 

  81. Misra M, Reaveley DA, Ashworth J, Muller B, Seed M, Brown EA. Six-month prospective cross-over study to determine the effects of 1.1% amino acid dialysate on lipid metabolism in patients on continuous ambulatory peritoneal dialysis. Perit Dial Int. 1997;17(3):279–86.

    Article  CAS  PubMed  Google Scholar 

  82. Tjiong HL, Swart R, Van den Berg JW, Fieren MW. Dialysate as food as an option for automated peritoneal dialysis. NDT Plus. 2008;1(Suppl 4):iv36–40.

    CAS  PubMed  PubMed Central  Google Scholar 

  83. Tjiong HL, van den Berg JW, Wattimena JL, Rietveld T, van Dijk LJ, van der Wiel AM, et al. Dialysate as food: combined amino acid and glucose dialysate improves protein anabolism in renal failure patients on automated peritoneal dialysis. J Am Soc Nephrol. 2005;16(5):1486.

    Article  CAS  PubMed  Google Scholar 

  84. Tjiong HL, Rietveld T, Wattimena JL, van den Berg JW, Kahriman D, van der Steen J, et al. Peritoneal dialysis with solutions containing amino acids plus glucose promotes protein synthesis during oral feeding. Clin J Am Soc Nephrol. 2007;2(1):74.

    Article  CAS  PubMed  Google Scholar 

  85. Garibotto G, Sofia A, Canepa A, Saffioti S, Sacco P, Sala M, et al. Acute effects of peritoneal dialysis with dialysates containing dextrose or dextrose and amino acids on muscle protein turnover in patients with chronic renal failure. J Am Soc Nephrol. 2001;12(3):557–67.

    Article  CAS  PubMed  Google Scholar 

  86. Wolfson M, Jones M. Intraperitoneal nutrition. Am J Kidney Dis. 1999;33(1):203–4.

    Article  CAS  PubMed  Google Scholar 

  87. Delarue J, Maingourd C, Objois M, Pinault M, Cohen R, Couet C, et al. Effects of an amino acid dialysate on leucine metabolism in continuous ambulatory peritoneal dialysis patients. Kidney Int. 1999;56(5):1934–43.

    Article  CAS  PubMed  Google Scholar 

  88. Park MS, Choi SR, Song YS, Yoon SY, Lee SY, Han DS. New insight of amino acid-based dialysis solutions. Kidney Int. 2006;70:S110–S4.

    Article  CAS  Google Scholar 

  89. Tjiong HL, Swart R, van den Berg JW, Fieren MW. Amino acid-based peritoneal dialysis solutions for malnutrition: new perspectives. Perit Dial Int. 2009;29(4):384–93.

    Article  CAS  PubMed  Google Scholar 

  90. Dombros N, Dratwa M, Feriani M, Gokal R, Heimburger O, Krediet R, et al. European best practice guidelines for peritoneal dialysis. 5 Peritoneal dialysis solutions. Nephrol Dial Transplant. 2005;20(Suppl 9):ix16–20.

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Case Study

Case Study

A 51-year-old Caucasian man (Mr. Smith) with a medical history of stage 5 CKD secondary to hypertension and glomerulonephritis presents with progressive decline of kidney function, poor appetite, nausea, lethargy, and decreased urine output. His nutritional assessment parameters are as follows: height = 170 cm; weight = 75.6 kg; BMI = 26.2 kg/m2; 5% unintentional weight loss over the past 3 months; SGA score = 4; serum albumin = 3.4 g/dL; and pedal edema. Peritoneal dialysis is started with the aim of removing excess fluid and uremic toxins, as well as improving nutritional status.

At 3 months after initiating peritoneal dialysis, Mr. Smith is feeling better. His pedal edema is resolving. His uremic symptoms, appetite, and oral intake are improving. His nutritional assessment parameters are as follows: dry body weight = 73.6 kg; BMI = 25.5 kg/m2; serum albumin = 4.0 g/dL; and SGA score = 6. Upon physical examination, Mr. Smith is euvolemic. His total intakes of protein and energy including the calories provided by the peritoneal dialysate are 1.3 g protein/kg/day and 33 kcal/kg/day, respectively.

Having been treated with peritoneal dialysis for 3 years, Mr. Smith is admitted to hospital due to turbid peritoneal effluent accompanied by constant abdominal pain. He had two prior episodes of peritonitis in the past few years. The laboratory findings and bacterial culture of the peritoneal dialysate confirm PD-associated peritonitis. At the same time, Mr. Smith experiences nausea, poor appetite, and reduced food intake. His food record chart indicates an ingestion of approximately 0.6 g protein/kg/day and 24 kcal/kg/day on the first few days of hospital admission.

Mr. Smith is given a 2-week course of intraperitoneal antibiotics upon diagnosis of peritonitis. He is also prescribed a trial of renal-specific ONS, providing an additional 25 g protein and 500 kcal daily. With the completion of the antibiotic therapy and the resolution of the peritonitis, improvements in appetite and oral intake are observed. He is subsequently discharged from the hospital. Upon hospital discharge, his estimated total protein and energy intakes including the use of ONS are 1.2 g/kg/day and 32 kcal/kg/day, respectively. His nutritional assessment parameters are as follows: dry weight = 71.5 kg; BMI = 24.7 kg/m2; 6% unintentional weight loss over the past 3 months; serum albumin = 3.4 g/dL; and SGA score = 4. In view of recurrent peritonitis, his renal replacement therapy is changed from peritoneal dialysis to hemodialysis.

At 2–3 months after transition to hemodialysis, his nutritional parameters are as follows: dry weight = 76.1 kg; BMI = 26.3 kg/m2; serum albumin = 4.1 g/dL; and SGA score = 6. Upon physical examination, he is euvolemic. His food diary shows an estimated consumption of 1.2 g protein/kg/day and 33 kcal/kg/day excluding the use of ONS.

Over the course of the next few years, he is relatively stable, and receives regular nutrition counseling from a registered dietitian. He is compliant with his hemodialysis regimen and manages to maintain nutritional assessment parameters within acceptable ranges. After 3–4 years on hemodialysis, Mr. Smith is admitted to hospital for 3 weeks with pneumonia. His nutritional assessment parameters immediately post-discharge are as follows: dry weight = 68.8 kg; BMI = 23.8 kg/m2; 9% unintentional weight loss over the past 2 months; temporal wasting indicated by physical examination; serum albumin = 3.2 g/dL; and SGA score = 4. His diet history indicates a spontaneous dietary intake of 0.9 g protein/kg/day and 25 kcal/kg/day.

Over the course of the next 3 months, there is no improvement in Mr. Smith’s nutritional assessment parameters. His nutritional status continues to decline despite liberalization of his diet and the use of ONS. His nutritional assessment parameters are as follows: dry weight = 64.2 kg; BMI = 22.2 kg/m2; unintentional weight loss of 7% over the past 3 months; muscle and fat wasting upon physical examination; serum albumin = 3.1 g/dL; and SGA score = 2. His diet history shows a consumption of 0.7 g protein/kg/day and 19 kcal/kg/day.

Although enteral tube feeding is proposed to Mr. Smith, he is very reluctant to attempt the suggested feeding methods including nasogastric tube feeding and percutaneous endoscopic gastrostomy feeding. With Mr. Smith’s agreement, the multidisciplinary team decides to commence IDPN. At 5 months after starting IDPN, there is only marginal improvement in Mr. Smith’s nutritional assessment parameters, and no improvement is observed for spontaneous dietary protein and energy intakes. IDPN is subsequently discontinued. After further discussion with Mr. Smith, he eventually consents to initiate enteral nutrition via nasogastric tube feeding. Subsequently, there are progressive improvements in spontaneous dietary protein and energy intakes, as well as various nutritional assessment parameters.

Case Questions and Answers

  1. 1.

    Is Mr. Smith presented with PEW upon initiation of peritoneal dialysis?

  • Answer: Yes, PEW can emerge in early CKD, and the risk of PEW increases as CKD progresses. Mr. Smith displays signs of PEW including poor appetite, nausea, 5% weight loss over the past 3 months, moderate PEW on SGA, and mild hypoalbuminemia.

  1. 2.

    Compared to nondialysis-dependent CKD, what are the specific concerns with the recommendations for dietary protein and energy intakes in maintenance peritoneal dialysis?

  • Answer: Compared to nondialysis-dependent CKD, higher protein and energy intakes are recommended by current evidence-based practice guidelines and expert consensus statement, that is, 1.0–1.5 g protein/kg BW/day and 25–35 kcal/kg BW/day. Every effort should be made to remove any unnecessary dietary restrictions. Education on calorie-dense foods and high biological value protein is necessary, as well as ways to improve oral intake.

  1. 3.

    After initiating peritoneal dialysis, should Mr. Smith aim for a dietary energy intake of 25–35 kcal/kg BW/day?

  • Answer: No, Mr. Smith absorbs calories from glucose in the dialysate, and the calories provided by the peritoneal dialysate should be subtracted from 25 to 35 kcal/kg BW/day to derive the target dietary energy intake.

  1. 4.

    Is Mr. Smith presented with PEW at 3 months after the initiation of peritoneal dialysis?

  • Answer: Mr. Smith has no obvious signs of PEW at 3 months after the initiation of peritoneal dialysis. His total protein and energy intakes are within the target requirement ranges, alongside improvements in appetite and oral intake. Although a reduction in body weight is observed, it is likely a resolution of volume overload reflected by euvolemia upon physical examination. Mr. Smith is no longer hypoalbuminemic, and his SGA score is not suggestive of PEW.

  1. 5.

    On the first day of his peritonitis-associated hospital admission, he was prescribed a renal menu (i.e., a menu that is protein-energy dense and low in electrolytes). Is this menu adequate as a form of nutrition support therapy? If not, what should be the next appropriate step of nutrition support and how would you optimize the outcome?

  • Answer: No, the prescription of a renal menu is insufficient to meet both protein and energy requirements. This is indicated by low protein and energy intakes on the food record chart, alongside reported symptoms of nausea, poor appetite, and reduced food intake. A full nutritional assessment is required, and the use of ONS should be considered as the next appropriate step. ONS should be prescribed based on the patient’s requirements, preference, compliance, and tolerance, as these are important success factors.

  1. 6.

    After his recovery from peritonitis, should he be discharged from the hospital with an ONS prescription?

  • Answer: Yes, although Mr. Smith is meeting both protein and energy requirements, it is derived from both oral diet and the use of ONS. An oral diet alone remains insufficient to attain the requirements. Mr. Smith is displaying signs of PEW including 6% unintentional weight loss over the past 3 months, hypoalbuminemia, and moderate PEW on SGA. Regular nutritional assessment and continuous dietary counseling are essential after the initiation of hemodialysis.

  1. 7.

    Should the use of ONS be discontinued at 2–3 months after transition to hemodialysis?

  • Answer: Yes, the use of ONS should be discontinued, because his nutritional status has improved with no obvious signs of PEW. He is attaining both protein and energy targets without the use of ONS.

  1. 8.

    Mr. Smith was prescribed a trial of renal-specific ONS during the episode of pneumonia-associated hospitalization. Should he continue to take the ONS after hospital discharge?

  • Answer: Yes, ONS should be continued upon hospital discharge, because Mr. Smith is displaying signs of PEW including unintentional weight loss, temporal wasting on physical examination, moderate PEW on SGA, and hypoalbuminemia. His spontaneous dietary protein and energy intakes are insufficient to meet protein and energy requirements, but both intakes are higher than the required minimum for ONS to be effective (e.g., 20–24 kcal/kg/day and 0.8–1.0 g protein/kg/day). Regular monitoring and intensive nutrition counseling are critical during the supplementation period. Implementing changes to the ONS prescription may be necessary to improve Mr. Smith’s adherence and hence the overall effectiveness of ONS.

  1. 9.

    Despite liberalization of his diet and the use of ONS, his nutritional status continues to decline. Is Mr. Smith an ideal candidate for enteral tube feeding ?

  • Answer: Yes, Mr. Smith is an ideal candidate for enteral tube feeding . He is exhibiting severe PEW on SGA, hypoalbuminemia, and unintentional weight loss of 7% over the past 3 months. His spontaneous dietary protein and energy intakes are <0.8 g/kg/day and <20 kcal/kg/day. Continuation of ONS and nutrition counseling are unlikely to achieve the recommended dietary protein and energy requirements. Daily nutrition support is important for Mr. Smith, and enteral nutrition should always be preferable to parenteral nutrition as feeding through the gastrointestinal tract helps to maintain its normal structure and function.

  1. 10.

    Should IDPN be discontinued after a trial period of 5 months?

  • Answer: Yes, most maintenance hemodialysis patients respond to IDPN after 3–6 months of therapy. Lack of improvement after 3–6 months should render a decision to discontinue.

Rights and permissions

Reprints and permissions

Copyright information

© 2020 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Chan, W. (2020). Nutrition Support in Hemodialysis and Peritoneal Dialysis. In: Burrowes, J., Kovesdy, C., Byham-Gray, L. (eds) Nutrition in Kidney Disease. Nutrition and Health. Humana, Cham. https://doi.org/10.1007/978-3-030-44858-5_17

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-44858-5_17

  • Published:

  • Publisher Name: Humana, Cham

  • Print ISBN: 978-3-030-44857-8

  • Online ISBN: 978-3-030-44858-5

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics